Business & Industry
Business & Industry
EU-US Trade Deal Taking Shape as Pharma Tariffs Materialize
Finally, the Trump administration’s much-animated tariffs on pharmaceutical imports are now materializing in a new EU-US trade deal. However, there are still many questions that...
BioPharma
AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D
AstraZeneca announces $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This investment is...
Business & Industry
Sino BioPharm to Acquire LaNova Medicines for $950.9 M Deal
LaNova Medicines, which happens to be a cancer drugmaker that previously licensed medicines to AstraZeneca as well as Merck & Co., has gone on to...
Business & Industry
Key Trends Shaping Indian Pharmaceutical Packaging Market
The pharmaceutical business has a major economic influence on both local and worldwide markets, and it is always changing according to different market trends. Packaging...
Business & Industry
Regional Pharma Hubs for Effective Supply Chain Outcomes
It is well to be noted that the pharmaceutical sector has for long been characterized by its intricate, global supply chains designed in order to...
Business & Industry
tHIS ASEAN 2025: Transforming Healthcare in Southeast Asia
Kuala Lumpur, 9 June 2025 - tHIS ASEAN 2025 today opened its doors at the Kuala Lumpur Convention Centre with the biggest and most diverse...
Business & Industry
Asia’s CROs VCs: Blurring Service Provider & Investor Roles
In a time characterized by accelerated innovation and ever-more complicated clinical environments, Asia is witnessing an invigorating shift in the role of Contract Research Organizations...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.